Saxenda ( DrugBank: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
193	プラダー・ウィリ症候群	3

193. プラダー・ウィリ症候群

臨床試験数 : 113 / 薬物数 : 111 - (DrugBank : 26) / 標的遺伝子数 : 48 - 標的パスウェイ数 : 102

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2014-004415-37-NL (EUCTR)	07/03/2016	17/08/2015	Effect of liraglutide for weight management in children with Prader-Willi Syndrome	Effect of liraglutide for weight management in paediatric subjects with Prader-Willi Syndrome. A ran ...	Obesity(Prader-Willi syndrome) MedDRA version: 18.1;Level: PT;Classification code 10029883;Term: Obe ...	Trade Name: Saxenda INN or Proposed INN: LIRAGLUTIDE	Novo Nordisk A/S	NULL	Not Recruiting			Female: yes Male: yes	60	Phase 3	France;United States;European Union;Canada;Turkey;Australia;Netherlands;Italy;New Zealand
2	EUCTR2014-004415-37-IT (EUCTR)	10/11/2015	29/07/2015	Effect of liraglutide for weight management in children with Prader-Willi Syndrome	Effect of liraglutide for weight management in paediatric subjects with Prader-Willi Syndrome. A ran ...	Obesity(Prader-Willi syndrome) MedDRA version: 18.0;Level: PT;Classification code 10029883;Term: Obe ...	Trade Name: Saxenda INN or Proposed INN: LIRAGLUTIDE	Novo Nordisk A/S	NULL	Not Recruiting			Female: yes Male: yes	60	Phase 3	France;United States;European Union;Canada;Turkey;Australia;Netherlands;New Zealand;Italy
3	EUCTR2014-004415-37-FR (EUCTR)		04/08/2015	Effect of liraglutide for weight management in children with Prader-Willi Syndrome	Effect of liraglutide for weight management in paediatric subjects with Prader-Willi Syndrome. A ran ...	Obesity(Prader-Willi syndrome) MedDRA version: 18.0;Level: PT;Classification code 10029883;Term: Obe ...	Trade Name: Saxenda INN or Proposed INN: LIRAGLUTIDE	Novo Nordisk A/S	NULL	Not Recruiting			Female: yes Male: yes	60	Phase 3	United States;France;European Union;Canada;Turkey;Australia;Netherlands;Italy;New Zealand

First Previous1Next Last